AU Stocks
US Stocks
US Options
Emerging Asia
Cash Management
Margin Lending
Smart Portfolio
MoneybullC
CTMX
Cytomx Therapeutics Inc
1.92
0.03+1.59%Opening13:42 05/20 EDT
OPEN/PREV CLOSE1.910/1.890
TODAY RANGE1.850-1.950
VOL1.06M
MARKET CAP149.61M
52 WEEK RANGE1.040-5.85
AVG VOL (3M)6.58M
% TURNOVER1.36%
TURNOVER0
P/E (TTM)9.71
% RANGE5.29%
EPS(TTM)0.1978
P/E(FORWARD)-10.2128
P/B-4.1299
BVPS-0.4649
DIVIDEND--
P/S1.277
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP141.25M
SHARES OUTSTANDING77.92M
NEXT EARNINGS08/06-08/12
FREE FLOAT73.57M
LOT SIZE1
EX-DIV DATE--
News
Press Releases
Financial Reports
Profile
Benzinga·05/09 18:59
Analysts' Varied Perspectives On CytomX's CX-904 Cancer Study: Safety Profile But Caution in Pancreatic Cancer
Benzinga·05/09 18:30
Gold Moves Higher; Roblox Issues Weak Outlook
Reuters·05/09 18:16
BUZZ-U.S. STOCKS ON THE MOVE-Hilton Grand Vacations, natgas firms, Silvaco
Benzinga·05/09 17:57
Why Duolingo Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Seeking Alpha·05/09 17:12
CCLD, SKYT and SEED among mid-day movers
Investorplace·05/09 16:51
SOUN Stock Alert: SoundHound AI Announces New Partnership With Perplexity
Investorplace·05/09 16:36
Dear NVDA Stock Fans, Mark Your Calendars for June 2
Benzinga·05/09 16:31
12 Health Care Stocks Moving In Thursday's Intraday Session
Reuters·05/09 16:05
BUZZ-U.S. STOCKS ON THE MOVE-Gold miners, Energy Transfer, Aercap
Benzinga·05/09 16:01
Dow Jumps Over 150 Points; US Foods Posts Upbeat Earnings
Investorplace·05/09 15:56
Why Is CytomX (CTMX) Stock Down 43% Today?
Seeking Alpha·05/09 15:33
CytomX slides after early data for Amgen-partnered cancer drug
Dow Jones·05/09 15:05
CytomX Therapeutics Price Target Raised to $3.59/Share From $3.25 by BMO Capital
Dow Jones·05/09 15:05
CytomX Therapeutics Is Maintained at Market Perform by BMO Capital
Same Industry
Name/Symbol
Change%
Price